8th Exosome-Based Therapeutic Development Summit

The 8th Exosome-Based Therapeutic Development Summit explores exosome-based therapeutics, extracellular vesicle technologies, translational development, manufacturing scalability, regulatory strategies, and diagnostic applications for advanced clinical innovation.

Key Topics

• Exosome potency assays and biological activity validation
• Regulatory frameworks for exosome therapeutics
• Clinical efficacy and safety data for extracellular vesicle therapies
• Batch-to-batch consistency in exosome manufacturing
• Preclinical translational models and biodistribution analysis
• Critical quality attributes and analytical control strategies
• Exosome diagnostics and liquid biopsy technologies
• Programmable natural nanoparticles for organ-targeted delivery
• Clinical trial design and dosing strategies for exosome therapeutics
• Exosome applications in inflammatory and autoimmune diseases
• Analytical testing and standardization of extracellular vesicle analysis
• Scalable manufacturing pathways for biologic therapeutics
• Microbial extracellular vesicles for clinical applications
• Predictive animal models and translational endpoints
• Precision medicine applications using exosome biomarkers
• Investment strategies and commercial opportunities in exosome therapeutics
• Tissue repair and regenerative exosome therapies
• Clinical translation of exosome-based diagnostics
• Quantitative tracking and validation strategies for biodistribution
• Central nervous system and neuroinflammatory therapeutic applications

Who should Attend

• Biopharmaceutical researchers and scientists
• Extracellular vesicle and exosome specialists
• Clinical development and translational medicine professionals
• Regulatory affairs and compliance experts
• Cell and gene therapy developers
• Biologics manufacturing and process development professionals
• Analytical testing and quality control specialists
• Drug discovery and preclinical research teams
• Precision medicine and diagnostics professionals
• Clinical trial and biomarker development experts
• Immunology and neuroscience researchers
• Investors and biotechnology business leaders
• Pharma and biotechnology executives
• Regenerative medicine and tissue repair specialists